Cobalamin-responsive disorders in the ambulatory care setting: Unreliability of cobalamin, methylmalonic acid, and homocysteine testing

Blood

Volumn 105, Issue 3, 2005, Pages 978-985

  Solomon, Lawrence R ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID;

AMBULATORY CARE; BLOOD ANALYSIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DOSE RESPONSE; DRUG DOSE REGIMEN; HEMATOLOGIC DISEASE; HUMAN; LABORATORY DIAGNOSIS; MACROCYTIC ANEMIA; NEUROLOGIC DISEASE; PREDICTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

EID: 12844254924     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1641     Document Type: Review

References (55)

1. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatrie disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720-1728.
2. Healton EB, Savage DG, Brust CM, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70:229-241.
3. Spivak JL. Masked megaloblastic anemia. Arch Intern Med. 1982;142:2111-2114.
4. Green R, Kuhl W, Jacobson R, Johnson C, Carmel R, Beutler E. Masking of macrocytosis by α-thalassemia in blacks with pernicious anemia. N Engl J Med. 1982;307:1322-1325.
5. Carmel, R. Pernicious anemia: the expected findings of very low serum cobalamin levels, anemia and macrocytosis are often lacking. Arch Intern Med. 1988;148:1712-1714.
6. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc. 1992;40:168-172.
7. Chanarin I. The response to specific therapy in the megaloblastic anaemias. In: The Megaloblastic Anaemias. 2nd ed. Oxford, United Kingdom: Blackwell Scientific Publications; 1979: 287-290.
8. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871-881.
9. Matchar DB, McCrory DC, Millington DS, Feussner JR. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci. 1994;308:276-283.
10. Moelby L, Rasmussen K, Jensen MK, Pedersen KO. The relationship between clinically confirmed cobalamin deficiency and serum methylmalonic acid. J Intern Med. 1990;228:373-378.
11. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency, II: relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:99-107.
12. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994;96:239-246.
13. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999;159:1289-1298.
14. Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest Suppl. 1994;219:61-76.
15. Green R. Screening for vitamin B12 deficiency: caveat emptor. Ann Intern Med. 1996:124:509-511.
16. Holleland G, Schneede J, Ueland PM, Lund PK, Refsum H, Sandberg S. Cobalamin deficiency in general practice: assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem. 1999;45:189-198.
17. Bolann BJ, Solli JD, Schneede J, et al. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid. Clin Chem. 2000;46:1744-1750.
18. Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol. 1997;97:695-700.
19. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate. Clin Chem. 2000;46:1277-1283.
20. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995;45:1435-1440.
21. Zittoun J, Zittoun R. Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol. 1999;36:35-46.
22. Carmel R, Brar S, Agrawal A, Penha PD. Failure of assay to identify low cobalamin concentrations [letter]. Clin Chem. 2000;46:2017-2018.
23. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60:2-11.
24. Bjorkegren K, Svardsudd K. Elevated levels of methylmalonic acid and homocysteine in elderly people: a population-based intervention study. J Intern Med. 1999;246:317-324.
25. Karnaze DS, Carmel R. Neurological and evoked potential abnormalities in subtle cobalamin deficiency states, including those without anemia and with normal absorption of free cobalamin. Arch Neurol. 1987;147:429-431.
26. Shinto NK. Serum vitamin B12 concentration in normal human adult serum assayed by Euglena gracilis. Clin Sci. 1959;18:389-398.
27. Chanarin I. The absence of vitamin B12. In: The Megaloblastic Anaemias. 2nd ed. Oxford, United Kingdom: Blackwell Scientific Publications; 1979: 133-141.
28. Rasmussen K, Moller J, Ostergaard K, Kristensen MO, Jensen J. Methylmalonic acid concentrations in serum of normal subjects: biological variability and the effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin. Clin Chem. 1990;36:1295-1299.
29. Garg UC, Zheng J, Folsom AR, et al. Short-term variability of plasma homocysteine measurement. Clin Chem. 1997;43:141-145.
30. Thirup P, Ekelund S. Day-to-day, postprandial and orthostatic variation of total plasma homocysteine. Clin Chem. 1999;45:1280-1283.
31. Santhosh-Kumar CR, Deutsch JC, Ryder JW, Kolhouse JF. Unpredictable intra-individual variations in serum homocysteine levels on folic acid supplementation. Eur J Clin Nutr. 1997;51:188-192.
32. Clarke R, Woodehouse P, Ulvik A, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem. 1998;44:102-107.
33. Rasmussen K, Moller J, Lyngbak M. Within-person variation of plasma homocysteine and effects of posture and tourniquet application. Clin Chem. 1999;45:1850-1855.
34. Cobbaert C, Arentsen JC, Mulder P, Hoogerbrugge M, Lindemans J. Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status. Clin Chem. 1997;43:1958-1964.
35. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40:1197-1204.
36. Hvas AM, Juul S, Gerdes LU, Nexo E. The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med. 2000;247:507-512.
37. Johnson MA, Hawthorne NA, Brackett WR, et al. Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr. 2003;77:211-220.
38. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr. 2002;132:2799-2803.
39. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr. 1998;15(suppl 2):S60-S66.
40. Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R. Transcobalamin II 775G>C and indices of vitamin B12 status in healthy older adults. Blood. 2002;100:718-720.
41. Lievers KJA, Afman LA, Kluijtmans LAJ, et al. Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem. 2002;48:1383-1389.
42. Ames BN, Elson-Schwab I, Silver EA. High dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002;75:616-658.
43. McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B12 deficiency and Alzheimer disease. Neurology. 2002;58:1395-1399.
44. Di Rocco A, Bottiglieri T, Werner P, et al. Abnormal cobalamin dependent transmethylation in AIDS-associated myelopathy. Neurology. 2002;58:730-735.
45. Yoshioka K, Tanaka K. Effect of methylcobalamin on diabetic autonomic neuropathy as assessed by power spectral analysis of heart rate variation. Horm Metab Res. 1995;27:41-42.
46. Utsunomiya K, Narabayashi I, Tamura K, et al. Effects of aldose reductase inhibitor and vitamin B12 on myocardial uptake of iodine-123 metaiodobenzylguanidine in patients with non-insulin-dependent diabetes mellitus. Eur J Nucl Med. 1998;25:1643-1648.
47. Kuwabra S, Nakazawa R, Azuma N, et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med. 1999;38:472-475.
48. Watananbe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci. 1994;122:140-143.
49. Pfohl-Leszkowicz A, Keith G, Dirheimer G. Effect of cobalamin derivatives on in vitro enzymatic DNA methylation: methylcobalamin can act as a methyl donor. Biochemistry. 1991;30:8045-8051.
50. Solomon LR, Hillman RS. Vitamin B6 metabolism in human red cells, I: variations in human red cells. Enzyme. 1978;23:262-273.
51. Solomon LR, Hillman RS. Regulation of vitamin B6 metabolism in human red cells. Am J Clin Nutr. 1979;32:1824-1831.
52. Solomon LR, Hillman RS. Vitamin B6 metabolism in idiopathic sideroblastic anaemia and related disorders. Br J Haematol. 1979;42:239-253.
53. Crouch JY, Solomon LR. Inhibition of rat liver transaminases by low levels of acedaldehyde and the pharmacologic effects of B6 vitamers. Biochem Pharmacol. 1989;38:3431-3437.
54. Solomon LR, Crouch JY. delta-Aminolevulinic acid dehydratase in rat liver: studies on the effects of ethanol, acetaldehyde and B6 vitamers. J Lab Clin Med. 1990;116:228-236.
55. Solomon LR, Cohen K. Erythrocyte oxygen transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes. 1989;38:881-886.